Nkarta Inc (NKTX)
2.45
+0.01
(+0.41%)
USD |
NASDAQ |
Nov 22, 16:00
2.48
+0.03
(+1.22%)
After-Hours: 20:00
Nkarta Total Liabilities (Quarterly): 101.16M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 101.16M |
June 30, 2024 | 100.90M |
March 31, 2024 | 103.28M |
December 31, 2023 | 105.60M |
September 30, 2023 | 109.05M |
June 30, 2023 | 111.06M |
March 31, 2023 | 111.52M |
December 31, 2022 | 100.73M |
September 30, 2022 | 104.54M |
June 30, 2022 | 82.60M |
Date | Value |
---|---|
March 31, 2022 | 77.59M |
December 31, 2021 | 22.94M |
September 30, 2021 | 22.45M |
June 30, 2021 | 20.73M |
March 31, 2021 | 19.70M |
December 31, 2020 | 16.43M |
September 30, 2020 | 17.31M |
June 30, 2020 | 127.50M |
March 31, 2020 | 15.00M |
December 31, 2019 | 73.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.00M
Minimum
Mar 2020
127.50M
Maximum
Jun 2020
72.20M
Average
91.67M
Median
Total Liabilities (Quarterly) Benchmarks
AMN Healthcare Services Inc | 1.777B |
Moderna Inc | 3.876B |
CEL-SCI Corp | 15.60M |
AIM ImmunoTech Inc | 10.68M |
IGC Pharma Inc | 2.992M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 532.03M |
Shareholders Equity (Quarterly) | 430.87M |